[go: up one dir, main page]

NO960339L - Fremgangsmåte for å inhibere restenose - Google Patents

Fremgangsmåte for å inhibere restenose

Info

Publication number
NO960339L
NO960339L NO960339A NO960339A NO960339L NO 960339 L NO960339 L NO 960339L NO 960339 A NO960339 A NO 960339A NO 960339 A NO960339 A NO 960339A NO 960339 L NO960339 L NO 960339L
Authority
NO
Norway
Prior art keywords
angioplasty
pharmaceutical composition
green porphyrin
inhibiting restenosis
preparation
Prior art date
Application number
NO960339A
Other languages
English (en)
Norwegian (no)
Other versions
NO960339D0 (no
Inventor
G Michael Vincent
Patricia M Logan
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of NO960339D0 publication Critical patent/NO960339D0/no
Publication of NO960339L publication Critical patent/NO960339L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Control Of Eletrric Generators (AREA)
NO960339A 1993-07-29 1996-01-26 Fremgangsmåte for å inhibere restenose NO960339L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/099,210 US5422362A (en) 1993-07-29 1993-07-29 Method to inhibit restenosis
PCT/US1994/008200 WO1995003797A1 (fr) 1993-07-29 1994-07-20 Procede d'inhibition de restenose

Publications (2)

Publication Number Publication Date
NO960339D0 NO960339D0 (no) 1996-01-26
NO960339L true NO960339L (no) 1996-03-26

Family

ID=22273603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960339A NO960339L (no) 1993-07-29 1996-01-26 Fremgangsmåte for å inhibere restenose

Country Status (13)

Country Link
US (1) US5422362A (fr)
EP (1) EP0711161A4 (fr)
JP (1) JP3146009B2 (fr)
KR (1) KR100256853B1 (fr)
CN (1) CN1127991A (fr)
AU (1) AU684301B2 (fr)
CA (1) CA2168043A1 (fr)
FI (1) FI960398A0 (fr)
IL (1) IL110455A0 (fr)
NO (1) NO960339L (fr)
PL (1) PL312796A1 (fr)
WO (1) WO1995003797A1 (fr)
ZA (1) ZA945657B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5824644A (en) * 1994-07-07 1998-10-20 G. D. Searle & Co. Method of attenuating arterial stenosis
US6107325A (en) * 1995-01-17 2000-08-22 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US5789433A (en) * 1995-01-17 1998-08-04 Quadra Logic Technologies, Inc. Green porphyrins as immunomodulators
US6096776A (en) * 1995-01-17 2000-08-01 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
US5948771A (en) * 1996-01-31 1999-09-07 The Trustees Of Columbia University In The City Of New York Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
US5834503A (en) * 1996-06-14 1998-11-10 Qlt Phototherapeutics, Inc. Methods to treat arterial plaque
US6043237A (en) * 1996-12-10 2000-03-28 Qlt Phototherapeutics, Inc. Use of photodynamic therapy for prevention of secondary cataracts
US6274614B1 (en) * 1997-02-11 2001-08-14 Qlt Inc. Methods, compositions and articles for reducing or preventing the effects of inflammation
EP0996465B1 (fr) 1997-02-11 2004-06-30 QLT Inc. Compositions et articles pour attenuer les consequences de l'inflammation
US6634363B1 (en) 1997-04-07 2003-10-21 Broncus Technologies, Inc. Methods of treating lungs having reversible obstructive pulmonary disease
US7992572B2 (en) 1998-06-10 2011-08-09 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US7027869B2 (en) 1998-01-07 2006-04-11 Asthmatx, Inc. Method for treating an asthma attack
US6488673B1 (en) * 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US5902299A (en) * 1997-07-29 1999-05-11 Jayaraman; Swaminathan Cryotherapy method for reducing tissue injury after balloon angioplasty or stent implantation
EP1039847A1 (fr) * 1997-12-15 2000-10-04 Prolifix Medical, Inc. Prothese endovasculaire de reduction de restenose
EP1955727B1 (fr) 1997-12-19 2011-02-23 Tyco Healthcare Group LP Ensemble distributeur pour mélange de fibrine
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US7198635B2 (en) 2000-10-17 2007-04-03 Asthmatx, Inc. Modification of airways by application of energy
US20070106348A1 (en) * 1998-06-10 2007-05-10 Asthmatx, Inc. Method for treating airways in the lung
US8181656B2 (en) 1998-06-10 2012-05-22 Asthmatx, Inc. Methods for treating airways
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
EP1166784B1 (fr) * 1999-04-02 2008-02-20 Meiji Seika Kaisha Ltd. Inhibition de la restenose vasculaire apres une angioplastie
US6609014B1 (en) * 1999-04-14 2003-08-19 Qlt Inc. Use of PDT to inhibit intimal hyperplasia
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
US7122568B1 (en) * 1999-11-17 2006-10-17 Qlt, Inc. Use of low-dose PDT to inhibit restenosis
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
US7104987B2 (en) 2000-10-17 2006-09-12 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
WO2002064163A2 (fr) 2001-02-15 2002-08-22 Qlt Inc. Procedes servant a limiter ou a empecher l'inflammation provoquee par une therapie photodynamique
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
CA2449828A1 (fr) * 2001-06-04 2003-01-16 The General Hospital Corporation Detection et therapie de plaques vulnerables a l'aide de composes photodynamiques
JP3990972B2 (ja) 2001-11-20 2007-10-17 有限会社 キック 血管再狭窄防止薬及び該防止薬がコーティングされた血管内埋め込み器具
US6783541B2 (en) 2001-11-21 2004-08-31 Miravant Medical Technologies, Inc. Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts
US6821289B2 (en) * 2003-03-25 2004-11-23 Ceramoptec Industries, Inc. Efficacy and safety of photodynamic therapy by multiple application protocols with photosensitizers that show extended tumor retention
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
WO2006049599A1 (fr) * 2004-10-28 2006-05-11 The General Hospital Corporation Methodes permettant de detecter et de traiter les plaques d'atherome par immunomodulation
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
CN102014779B (zh) 2008-05-09 2014-10-22 赫莱拉公司 用于治疗支气管树的系统、组件和方法
US9186411B2 (en) 2008-07-28 2015-11-17 Takeda Pharmaceutical Company Limited Pharmaceutical composition
CN104856757B (zh) 2009-10-27 2017-06-23 赫莱拉公司 具有可冷却的能量发射组件的递送装置
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
AU2010319477A1 (en) 2009-11-11 2012-05-24 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
EP3868321B1 (fr) 2012-06-04 2022-11-16 Boston Scientific Scimed, Inc. Systèmes pour le traitement d'un tissu dans une voie de passage au sein d'un corps
US9592086B2 (en) 2012-07-24 2017-03-14 Boston Scientific Scimed, Inc. Electrodes for tissue treatment
US9272132B2 (en) 2012-11-02 2016-03-01 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
US9283374B2 (en) 2012-11-05 2016-03-15 Boston Scientific Scimed, Inc. Devices and methods for delivering energy to body lumens
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
EP3335658B1 (fr) 2013-08-09 2020-04-22 Boston Scientific Scimed, Inc. Cathéter expansible
CA3064782A1 (fr) * 2017-05-26 2018-11-29 Altum Pharmaceuticals Inc. Administration de cannabinoide biphasique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5308608A (en) * 1989-06-07 1994-05-03 University Of British Columbia Photosensitizing Diels-Alder porphyrin derivatives
US5214036A (en) * 1990-03-08 1993-05-25 University Of British Columbia Benzoporphyrin derivatives for photodynamic therapy
US5116864A (en) * 1991-04-09 1992-05-26 Indiana University Foundation Method for preventing restenosis following reconfiguration of body vessels
JP3154742B2 (ja) * 1991-04-30 2001-04-09 日本石油化学株式会社 哺乳類の動脈硬化症治療剤

Also Published As

Publication number Publication date
CN1127991A (zh) 1996-07-31
KR960703585A (ko) 1996-08-31
IL110455A0 (en) 1994-10-21
NO960339D0 (no) 1996-01-26
ZA945657B (en) 1996-01-29
FI960398A0 (fi) 1996-01-29
AU684301B2 (en) 1997-12-11
AU7401794A (en) 1995-02-28
EP0711161A4 (fr) 1997-07-30
WO1995003797A1 (fr) 1995-02-09
US5422362A (en) 1995-06-06
EP0711161A1 (fr) 1996-05-15
JP3146009B2 (ja) 2001-03-12
JPH09503998A (ja) 1997-04-22
CA2168043A1 (fr) 1995-02-09
PL312796A1 (en) 1996-05-13
KR100256853B1 (ko) 2000-05-15

Similar Documents

Publication Publication Date Title
NO960339L (no) Fremgangsmåte for å inhibere restenose
Ramsay Solar urticaria treatment by inducing tolerance to artificial radiation and natural light
DK160460C (da) Insulinpraeparat til nasal eller rektal administration og anvendelse af et insulinderivat til fremstilling af praeparatet
DE58909793D1 (de) Neue Benzopyran-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltenden Zubereitungen
DK0532862T3 (da) Anvendelse af rapamycin til fremstilling af et lægemiddel til behandling af øjeninflammation
NO985829L (no) Anvendelse av gr°nne porfyriner for fremstilling av et medikament for behandling av aterosklerose uten formÕlsbestemt strÕling av porfyrinderivatene
CA2149636A1 (fr) Methode d'activation d'agens photosensibles
ATE216220T1 (de) Osmotische darreichungsform mit zwei mantelschichten
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
NO971539L (no) Behandling av multippel sklerose (MS) og andre demyelinerende tilstander ved bruk av lofepramin i kombinasjon med L-fenylalanin tyrosin eller tryptofan og eventuelt en vitamin B12-forbindelse
DK0393493T3 (da) Fluorerede galdesyrederivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
JPS57193411A (en) Prevention of prostatic hyperplasia and therapeutical drug
RU95105973A (ru) Способ снижения тяжести токсоплазмоза, фармацевтическая композиция, применение производных рифамицина для получения лекарственных препаратов для лечения токсоплазмоза
IS2216B (is) Meðferðaráform við inngjöf á H+,K+ -ATPasa-hemla
RU94029667A (ru) ПРОИЗВОДНЫЕ 11β -БЕНЗАЛЬДОКСИМ-ЭСТРА-4,9-ДИЕНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ЛЕКАРСТВЕННЫЕ СРЕДСТВА
KR890700026A (ko) 건선 치료에 있어서 주석 프로토포르피린 및 주석 메조포르피린의 용도
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
NO955085L (no) Androstansteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder
NO993841D0 (no) Blandinger og anordninger for redusering av virkningene av inflamasjon
EP0720855A3 (fr) Composition pour le traitement de l'hypertension contenant des sels de potassium autres que les halogénures
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
WO2003045311A3 (fr) Procedes permettant d'inhiber ou d'eliminer la stenose de fistules et de greffes arterioveineuses
Levins et al. A new liquid formulation of 8-methoxypsoralen: bioactivity and effect of diet
DE69300296D1 (de) Thiochromanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application